KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Non-cash Items (2021 - 2022)

Historic Non-cash Items for AbCellera Biologics (ABCL) over the last 2 years, with Q4 2022 value amounting to $113.4 million.

  • AbCellera Biologics' Non-cash Items rose 11296081.75% to $113.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $113.4 million, marking a year-over-year increase of 11296081.75%. This contributed to the annual value of $113.4 million for FY2022, which is 11296081.75% up from last year.
  • Per AbCellera Biologics' latest filing, its Non-cash Items stood at $113.4 million for Q4 2022, which was up 11296081.75% from $22.5 million recorded in Q3 2022.
  • AbCellera Biologics' 5-year Non-cash Items high stood at $113.4 million for Q4 2022, and its period low was $100300.0 during Q4 2021.